Zota Health Care logo

Zota Health Care MD, chairman, board of directors and AGM

NSE: ZOTAPharmaceuticals & BiotechnologySmall Cap

Last close ₹1,242.70down ₹30.40 (2.39%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹1,273.10.

52-week range of traded prices to 23 Oct 2026
₹1,022.00Low, 2 Sep 2026₹1,740.00High, 21 Nov 2025
Market cap
₹4,304 Cr838th largest listed
P/E
Lossover the last 12 months
P/B
6.2
Dividend yield
0.08%
ROE
−22.5%
ROCE
−12.8%
Debt to equity
0.04
Volume, NSE
73,93258.6% delivered

Zota Health Care board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonKetankumar Chandulal ZotaRelated to the promoter
  • Managing directorMoxesh ketanbhai Zota
  • Company Secretary and Compliance OfficerAshvin Variya

12 directors6 independent5 executive1 non-executive

  • Ketankumar Chandulal Zota · ChairpersonNon-executive · joined Jul 2000 · reappointed Oct 2016 · 1 listed board
  • Moxesh ketanbhai Zota · Managing directorExecutive · joined Oct 2016 · reappointed Oct 2021 · 1 listed board
  • Kamlesh Rajanikant ZotaExecutive · joined Jul 2000 · reappointed Apr 2025 · 1 listed board
  • Himanshu Muktilal ZotaExecutive · joined Jul 2000 · reappointed Apr 2025 · 1 listed board · 4 committee seats
  • Viren Manukant ZotaExecutive · joined Apr 2024 · reappointed Apr 2024 · 1 listed board · 1 committee seat
  • Varshabahen Gaurang MehtaIndependent · joined Sep 2016 · reappointed Sep 2021 · 118 months as independent · 1 listed board · 1 as independent · 1 committee seat
  • Bhumi Maulik DoshiIndependent · joined May 2019 · reappointed May 2024 · 85 months as independent · 1 listed board · 1 as independent · 1 committee seat
  • Vitrag Sureshkumar ModiIndependent · joined May 2019 · reappointed May 2024 · 85 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
  • Dhiren Prafulbhai ShahIndependent · joined Sep 2019 · reappointed Sep 2024 · 82 months as independent · 1 listed board · 1 as independent
  • Jayshreeben Nileshkumar MehtaIndependent · joined Sep 2019 · reappointed Sep 2024 · 82 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
  • Laxmi Kant SharmaExecutive · joined Aug 2023 · reappointed Aug 2023 · 1 listed board
  • Dhaval Chandubhai PatwaIndependent · joined Aug 2023 · reappointed Aug 2023 · 34 months as independent · 1 listed board · 1 as independent · 1 committee seat

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 22 Jun 202612 of 12 present6 independent · 30 days in between
    • 22 May 202612 of 12 present6 independent · 69 days in between
    • 13 Mar 202611 of 12 present5 independent · 24 days in between
    • 16 Feb 202612 of 12 present6 independent · 11 days in between
    3 earlier meetings
    • 4 Feb 202612 of 12 present6 independent · 17 days in between
    • 17 Jan 20269 of 12 present6 independent · 14 days in between
    • 2 Jan 202612 of 12 present6 independent
  • Audit Committee

    Chair Vitrag Sureshkumar Modi

    Varshabahen Gaurang Mehta, Himanshu Muktilal Zota, Bhumi Maulik Doshi

    • 22 May 20264 of 4 present3 independent · 106 days in between
    • 4 Feb 20264 of 4 present3 independent
  • Nomination and remuneration committee

    Chair Varshabahen Gaurang Mehta

    Dhiren Prafulbhai Shah, Jayshreeben Nileshkumar Mehta

    • 13 May 20263 of 3 present3 independent · 81 days in between
    • 20 Feb 20263 of 3 present3 independent
  • Stakeholders Relationship Committee

    Chair Jayshreeben Nileshkumar Mehta

    Himanshu Muktilal Zota, Viren Manukant Zota

    • 31 Mar 20263 of 3 present1 independent · 45 days in between
  • Risk Management Committee

    Chair Moxesh ketanbhai Zota

    Himanshu Muktilal Zota, Dhaval Chandubhai Patwa

    • 13 Feb 20263 of 3 present1 independent
  • Corporate Social Responsibility Committee

    Chair Himanshu Muktilal Zota

    Ketankumar Chandulal Zota, Varshabahen Gaurang Mehta

    • 12 Jun 20263 of 3 present1 independent · 20 days in between
  • Fund Raising Committee

    Chair Himanshu Muktilal Zota

    Moxesh ketanbhai Zota, Vitrag Sureshkumar Modi

    No meeting listed in the filing.

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Jun 2026.

  • Pradeep K Singhi & AssociatesPeer-review certificate valid to Mar 2027

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Zota Health Care AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Zota Health Care dividend history

Annual general meeting, 28 Sep 2026

15,862 shareholders on the register on 21 Sep 2026; present: 11 promoters and 22 others; votes counted by RANJIT BINOD KEJRIWAL / RANJIT BINOD KEJRIWAL.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended on March 31, 2026, together with the Reports of the Board of Directors and Auditors thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 51.08% · promoters 67.57% · institutions 71.09% · other public 21.45%

  2. Declaration of final dividend on equity shares @ 10% i.e. Re. 1/- per equity share for FY 2025-26
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 51.08% · promoters 67.57% · institutions 71.09% · other public 21.45%

  3. To appoint the Director in place of Mr. Kamlesh Rajanikant Zota (DIN: 00822705), Whole-time Director of the Company, who shall retire by rotation in terms with Section 152(6) of the Companies Act, 2013 and being eligible, seeks re-appointmentMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 51.08% · promoters 67.57% · institutions 71.09% · other public 21.45%

  4. To appoint Mr. Mahaveer Dhariwal (DIN: 11893880) as the Independent Director of the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 51.08% · promoters 67.57% · institutions 71.09% · other public 21.45%

  5. To re-appoint Mr. Moxesh Ketanbhai Zota (DIN: 07625219) as the Managing Director of the Company
    Special
    98.98% for1.02% against

    Against: promoters 0.00% · institutions 5.46% · other public 0.00%

    Turnout: all 50.79% · promoters 67.57% · institutions 68.96% · other public 21.45%

  6. To approve the remuneration payable to Mr. Ketankumar Chandulal Zota (DIN: 00822594), Non-Executive Chairman of the Company
    Special
    98.97% for1.03% against

    Against: promoters 0.00% · institutions 5.51% · other public 0.00%

    Turnout: all 50.79% · promoters 67.57% · institutions 68.96% · other public 21.45%

  7. To approve the related party transactions with respect to payment of remunerations or salary to Directors and Senior Marketing Manager of the Company
    OrdinaryPromoters have an interest in it
    97.04% for2.96% against

    Against: promoters 0.00% · institutions 5.34% · other public 0.00%

    Turnout: all 17.72% · promoters 0.01% · institutions 71.09% · other public 21.44%

  8. To approve material related party transaction(s) between the Company and M/s Everyday Herbal Beauty Care Limited, Subsidiary of the Company
    OrdinaryPromoters have an interest in it
    97.07% for2.94% against

    Against: promoters 0.00% · institutions 5.29% · other public 0.00%

    Turnout: all 17.72% · promoters 0.01% · institutions 71.09% · other public 21.44%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 16 Apr 2026, 1 resolution

14,154 shareholders on the register on 13 Mar 2026; votes counted by RANJIT BINOD KEJRIWAL / RANJIT BINOD KEJRIWAL.The company's voting result (opens in a new tab)

  1. AUTHORISING THE BOARD TO GIVE LOAN, GUARANTEE OR SECURITY IN CONNECTION WITH A LOAN TO ANY PERSON OR OTHER BODY CORPORATE AND ACQUISITION OF SECURITIES OF ANY OTHER BODY CORPORATE IN EXCESS OF THE LIMITS SPECIFIED UNDER SECTION 186 OF THE COMPANIES ACT, 2013MoreLess
    Special
    97.96% for2.04% against

    Against: promoters 0.00% · institutions 6.23% · other public 1.12%

    Turnout: all 41.16% · promoters 43.74% · institutions 83.39% · other public 20.55%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 29 Sep 2025, 14 resolutions

12,129 shareholders on the register on 22 Sep 2025; present: 9 promoters and 34 others; votes counted by RANJIT BINOD KEJRIWAL / RANJIT BINOD KEJRIWAL.The company's voting result (opens in a new tab)

  1. TO RECEIVE, CONSIDER AND ADOPT THE AUDITED STANDALONE AND CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED ON 31ST MARCH, 2025, TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS AND AUDITORS THEREON.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 54.16% · promoters 71.88% · institutions 17.27% · other public 37.86%

  2. DECLARATION OF FINAL DIVIDEND ON EQUITY SHARES @ 10% I.E. RE.1/- PER EQUITY SHARE FOR THE FINANCIAL YEAR 2024-25.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 54.16% · promoters 71.88% · institutions 17.27% · other public 37.86%

  3. TO APPOINT A DIRECTOR IN PLACE OF MR. LAXMI KANT SHARMA, EXECUTIVE DIRECTOR (HOLDING DIN: 10266796), WHO RETIRE BY ROTATION IN TERMS OF SECTION 152(6) OF THE COMPANIES ACT, 2013 AND BEING ELIGIBLE, SEEKS RE-APPOINTMENT.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 54.16% · promoters 71.88% · institutions 17.27% · other public 37.86%

  4. TO APPROVE APPOINTMENT OF MR. RANJIT BINOD KEJRIWAL, A PEER REVIEWED COMPANY SECRETARY, AS THE SECRETARIAL AUDITOR OF THE COMPANY.
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.04%

    Turnout: all 54.16% · promoters 71.88% · institutions 17.27% · other public 37.86%

  5. TO APPROVE THE REMUNERATION PAYABLE TO MR. KETANKUMAR CHANDULAL ZOTA (DIN: 00822594), NON-EXECUTIVE CHAIRMAN OF THE COMPANY.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 35.29% · promoters 38.07% · institutions 17.27% · other public 37.86%

  6. TO APPROVE REVISION IN REMUNERATION PAYABLE TO MR. MOXESH KETANBHAI ZOTA (DIN: 07625219), MANAGING DIRECTOR OF THE COMPANY.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 35.29% · promoters 38.07% · institutions 17.27% · other public 37.86%

  7. TO APPROVE REVISION IN REMUNERATION PAYABLE TO MR. KAMLESH RAJANIKANT ZOTA (DIN: 00822705), WHOLE-TIME DIRECTOR OF THE COMPANY.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 35.29% · promoters 38.07% · institutions 17.27% · other public 37.86%

  8. TO APPROVE REVISION IN REMUNERATION PAYABLE TO MR. HIMANSHU MUKTILAL ZOTA (DIN: 01097722), WHOLE-TIME DIRECTOR OF THE COMPANY.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 35.29% · promoters 38.07% · institutions 17.27% · other public 37.86%

  9. TO APPROVE REVISION IN REMUNERATION PAYABLE TO MR. VIREN MANUKANT ZOTA (DIN: 08656333), WHOLE-TIME DIRECTOR OF THE COMPANY.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 35.29% · promoters 38.07% · institutions 17.27% · other public 37.86%

  10. TO APPROVE REVISION IN REMUNERATION PAYABLE TO MR. LAXMI KANT SHARMA (DIN-10266796), EXECUTIVE DIRECTOR OF THE COMPANY.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 54.16% · promoters 71.88% · institutions 17.27% · other public 37.86%

  11. TO APPROVE MATERIAL RELATED PARTY TRANSACTION(S) WITH RESPECT TO REVISION OF PAYMENT OF REMUNERATION
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 39.82% · promoters 46.19% · institutions 17.27% · other public 37.86%

  12. TO APPROVE MATERIAL RELATED PARTY TRANSACTION(S) BETWEEN THE COMPANY AND M/S EVERYDAY HERBAL BEAUTY CARE PRIVATE LIMITED, SUBSIDIARY OF THE COMPANY.
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 38.22% · promoters 43.33% · institutions 17.27% · other public 37.86%

  13. TO APPROVE INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 54.16% · promoters 71.88% · institutions 17.27% · other public 37.86%

  14. TO CONSIDER AND APPROVE THE PROPOSAL FOR FUND RAISING IN ONE OR MORE TRANCHES BY WAY OF ISSUANCE OF EQUITY SHARES AND/OR EQUITY LINKED SECURITIES BY WAY OF QUALIFIED INSTITUTIONAL PLACEMENT.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 54.16% · promoters 71.88% · institutions 17.27% · other public 37.86%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Extraordinary general meeting, 26 Mar 2025, 3 resolutions

10,618 shareholders on the register on 21 Mar 2025; present: 9 promoters and 27 others; votes counted by Ranjit Binod Kejriwal.The company's voting result (opens in a new tab)

  1. ISSUANCE OF EQUITY SHARES ON A PREFERENTIAL BASIS TO THE NON-PROMOTER GROUP CATEGORY
    Special
    99.87% for0.13% against

    Against: promoters 0.00% · institutions 0.00% · other public 76.52%

    Turnout: all 41.34% · promoters 69.06% · institutions 0.75% · other public 0.19%

  2. AUTHORISING THE BOARD TO GIVE LOAN, GUARANTEE OR SECURITY IN CONNECTION WITH A LOAN TO ANY PERSON OR OTHER BODY CORPORATE AND ACQUISITION OF SECURITIES OF ANY OTHER BODY CORPORATE IN EXCESS OF THE LIMITS SPECIFIED UNDER SECTION 186 OF THE COMPANIES ACT, 2013MoreLess
    Special
    99.87% for0.13% against

    Against: promoters 0.00% · institutions 0.00% · other public 76.52%

    Turnout: all 41.34% · promoters 69.06% · institutions 0.75% · other public 0.19%

  3. APPROVAL FOR GIVING LOAN OR GUARANTEE OR PROVIDING SECURITY IN CONNECTION WITH LOAN AVAILED BY EVERYDAY HERBAL BEAUTY CARE PRIVATE LIMITED, IN WHOM ANY OF THE DIRECTOR OF THE COMPANY IS INTERESTED UNDER SECTION 185 OF THE COMPANIES ACT, 2013MoreLess
    Special
    99.87% for0.13% against

    Against: promoters 0.00% · institutions 0.00% · other public 77.04%

    Turnout: all 41.34% · promoters 69.06% · institutions 0.75% · other public 0.19%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Extraordinary general meeting, 5 Feb 2025, 2 resolutions

10,363 shareholders on the register on 31 Jan 2025; present: 19 promoters and 13 others; votes counted by Ranjit Binod Kejriwal.The company's voting result (opens in a new tab)

  1. ISSUANCE OF EQUITY SHARES ON A PREFERENTIAL BASIS TO THE NON-PROMOTER GROUP CATEGORY
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 34.61% · promoters 42.71% · institutions 2.81% · other public 22.16%

  2. ISSUANCE OF FULLY CONVERTIBLE WARRANTS ON A PREFERENTIAL BASIS TO THE NON-PROMOTER GROUP CATEGORY
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 34.61% · promoters 42.71% · institutions 2.81% · other public 22.16%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 28 Sep 2024, 9 resolutions

Present: 7 promoters and 30 others.The company's voting result (opens in a new tab)

  1. TO RECEIVE, CONSIDER AND ADOPT THE AUDITED STANDALONE AND CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED ON 31ST MARCH, 2024, TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS AND AUDITORS THEREON.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 61.55% · promoters 83.74% · institutions 0.00% · other public 25.39%

  2. DECLARATION OF FINAL DIVIDEND ON EQUITY SHARES @ 10% I.E. RE.1/- PER EQUITY SHARE FOR THE FINANCIAL YEAR 2023-24
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 61.55% · promoters 83.74% · institutions 0.00% · other public 25.39%

  3. TO APPOINT A DIRECTOR IN PLACE OF MR. KETANKUMAR CHANDULAL ZOTA, DIRECTOR (HOLDING DIN: 00822594), WHO RETIRE BY ROTATION INnTERMS OF SECTION 152(6) OF THE COMPANIES ACT, 2013 AND BEING ELIGIBLE, SEEKS RE-APPOINTMENTMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 45.52% · promoters 58.05% · institutions 0.00% · other public 25.38%

  4. APPOINTMENT OF STATUTORY AUDITOR AND AUTHORISE DIRECTORS TO APPROVE THEIR REMUNERATION
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 61.55% · promoters 83.74% · institutions 0.00% · other public 25.39%

  5. TO RE-APPOINT MR. DHIREN PRAFULBHAI SHAH (DIN: 08536409) AS A NON-EXECUTIVE INDEPENDENT DIRECTOR OF THE COMPANY
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 61.55% · promoters 83.74% · institutions 0.00% · other public 25.39%

  6. TO RE-APPOINT MRS. JAYSHREEBEN NILESHKUMAR MEHTA (DIN: 08536399) AS A NON-EXECUTIVE INDEPENDENT DIRECTOR OF THE COMPANY
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 61.55% · promoters 83.74% · institutions 0.00% · other public 25.39%

  7. TO RE-APPOINT MR. HIMANSHU MUKTILAL ZOTA (DIN: 01097722) AS A WHOLE-TIME DIRECTOR OF THE COMPANY
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 61.55% · promoters 83.74% · institutions 0.00% · other public 25.39%

  8. TO RE-APPOINT MR. KAMLESH RAJANIKANT ZOTA (DIN: 00822705) AS A WHOLE- TIME DIRECTOR OF THE COMPANY
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 49.06% · promoters 63.72% · institutions 0.00% · other public 25.39%

  9. TO APPROVE MATERIAL RELATED PARTY TRANSACTION
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 25.40% · promoters 26.80% · institutions 0.00% · other public 23.70%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 27 Aug 2024, 2 resolutions

Present: 0 promoters and 0 others.The company's voting result (opens in a new tab)

  1. TO RE-APPOINT MRS. BHUMI MAULIK DOSHI (DIN: 08456082) AS A NON- EXECUTIVE INDEPENDENT DIRECTOR
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.04%

    Turnout: all 26.24% · promoters 38.59% · institutions 0.00% · other public 3.86%

  2. TO RE-APPOINT MR. VITRAG SURESHKUMAR MODI (DIN: 08457204) AS A NON- EXECUTIVE INDEPENDENT DIRECTOR
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 26.24% · promoters 38.59% · institutions 0.00% · other public 3.86%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Extraordinary general meeting, 13 Jul 2024, 3 resolutions

Present: 6 promoters and 32 others.The company's voting result (opens in a new tab)

  1. TO CONSIDER AND APPROVE INCREASE OF THE AUTHORIZED SHARE CAPITAL OF THE COMPANY BY AMENDING THE MEMORANDUM OF ASSOCIATION OF THE COMPANY
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 51.21% · promoters 65.63% · institutions 0.00% · other public 25.09%

  2. ISSUANCE OF EQUITY SHARES ON A PREFERENTIAL BASIS TO THE PROMOTER GROUP AND NON - PROMOTER GROUP CATEGORY
    SpecialPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 51.21% · promoters 65.63% · institutions 0.00% · other public 25.09%

  3. ISSUANCE OF FULLY CONVERTIBLE WARRANTS ON A PREFERENTIAL BASIS TO PROMOTER GROUP AND NON - PROMOTER GROUP CATEGORY
    SpecialPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.07%

    Turnout: all 51.21% · promoters 65.63% · institutions 0.00% · other public 25.09%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.

Mutual fund votes, meeting of 16 Apr 2026, 1 fund house

  • AUTHORISING THE BOARD TO GIVE LOAN, GUARANTEE OR SECURITY IN CONNECTION WITH A LOAN TO ANY PERSON OR OTHER BODY CORPORATE AND ACQUISITION OF SECURITIES OF ANY OTHER BODY CORPORATE IN EXCESS OF THE LIMITS SPECIFIED UNDER SECTION 186 OF THE COMPANIES ACT, 2013MoreLess
    1 for0 against

Mutual fund votes, meeting of 29 Sep 2025, 1 fund house

  • TO RECEIVE, CONSIDER AND ADOPT THE AUDITED STANDALONE AND CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED ON 31ST MARCH, 2025, TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS AND AUDITORS THEREON.MoreLess
    1 for0 against
  • DECLARATION OF FINAL DIVIDEND ON EQUITY SHARES @ 10% I.E. RE.1/- PER EQUITY SHARE FOR THE FINANCIAL YEAR 2024-25.
    1 for0 against
  • TO APPOINT A DIRECTOR IN PLACE OF MR. LAXMI KANT SHARMA, EXECUTIVE DIRECTOR (HOLDING DIN: 10266796), WHO RETIRE BY ROTATION IN TERMS OF SECTION 152(6) OF THE COMPANIES ACT, 2013 AND BEING ELIGIBLE, SEEKS RE-APPOINTMENT.MoreLess
    1 for0 against
  • TO APPROVE APPOINTMENT OF MR. RANJIT BINOD KEJRIWAL, A PEER REVIEWED COMPANY SECRETARY, AS THE SECRETARIAL AUDITOR OF THE COMPANY.
    1 for0 against
  • TO APPROVE THE REMUNERATION PAYABLE TO MR. KETANKUMAR CHANDULAL ZOTA (DIN: 00822594), NON-EXECUTIVE CHAIRMAN OF THE COMPANY.
    1 for0 against
  • TO APPROVE REVISION IN REMUNERATION PAYABLE TO MR. MOXESH KETANBHAI ZOTA (DIN: 07625219), MANAGING DIRECTOR OF THE COMPANY.
    1 for0 against
  • TO APPROVE REVISION IN REMUNERATION PAYABLE TO MR. KAMLESH RAJANIKANT ZOTA (DIN: 00822705), WHOLE-TIME DIRECTOR OF THE COMPANY.
    1 for0 against
  • TO APPROVE REVISION IN REMUNERATION PAYABLE TO MR. HIMANSHU MUKTILAL ZOTA (DIN: 01097722), WHOLE-TIME DIRECTOR OF THE COMPANY.
    1 for0 against
  • TO APPROVE REVISION IN REMUNERATION PAYABLE TO MR. VIREN MANUKANT ZOTA (DIN: 08656333), WHOLE-TIME DIRECTOR OF THE COMPANY.
    1 for0 against
  • TO APPROVE REVISION IN REMUNERATION PAYABLE TO MR. LAXMI KANT SHARMA (DIN-10266796), EXECUTIVE DIRECTOR OF THE COMPANY.
    1 for0 against
  • TO APPROVE MATERIAL RELATED PARTY TRANSACTION(S) WITH RESPECT TO REVISION OF PAYMENT OF REMUNERATION
    1 for0 against
  • TO APPROVE MATERIAL RELATED PARTY TRANSACTION(S) BETWEEN THE COMPANY AND M/S EVERYDAY HERBAL BEAUTY CARE PRIVATE LIMITED, SUBSIDIARY OF THE COMPANY.
    1 for0 against
  • TO APPROVE INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY
    1 for0 against
  • TO CONSIDER AND APPROVE THE PROPOSAL FOR FUND RAISING IN ONE OR MORE TRANCHES BY WAY OF ISSUANCE OF EQUITY SHARES AND/OR EQUITY LINKED SECURITIES BY WAY OF QUALIFIED INSTITUTIONAL PLACEMENT.
    1 for0 against
2 earlier meetings

Mutual fund votes, meeting of 26 Mar 2025, 1 fund house

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • AUTHORISING THE BOARD TO GIVE LOAN, GUARANTEE OR SECURITY IN CONNECTION WITH A LOAN TO ANY PERSON OR OTHER BODY CORPORATE AND ACQUISITION OF SECURITIES OF ANY OTHER BODY CORPORATE IN EXCESS OF THE LIMITS SPECIFIED UNDER SECTION 186 OF THE COMPANIES ACT, 2013MoreLess
    1 for0 against
  • APPROVAL FOR GIVING LOAN OR GUARANTEE OR PROVIDING SECURITY IN CONNECTION WITH LOAN AVAILED BY EVERYDAY HERBAL BEAUTY CARE PRIVATE LIMITED, IN WHOM ANY OF THE DIRECTOR OF THE COMPANY IS INTERESTED UNDER SECTION 185 OF THE COMPANIES ACT, 2013MoreLess
    1 for0 against
1 proposal not matched to one resolution
  • To create, offer, issue and allot, up to 7,95,000 Equity Shares having face value of Rs. 10/- each, at an issue price of Rs. 900/- per Equity Share (including premium of Rs. 890/-) aggregating to an amount of up to Rs. 71,55,00,000/- or price which is determine in accordance with Chapter V of the SEBI ICDR Regulations, 2018 whichever is higher, for consideration in cash, by way of Preferential Allotment in one or more tranches (hereinafter referred to as Proposed Allottee(s).MoreLess
    1 for0 against

Mutual fund votes, meeting of 5 Feb 2025, 1 fund house

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • ISSUANCE OF FULLY CONVERTIBLE WARRANTS ON A PREFERENTIAL BASIS TO THE NON-PROMOTER GROUP CATEGORY
    1 for0 against
1 proposal not matched to one resolution
  • To create, offer, issue and allot, up to 11,50,000 Equity Shares having face value of Rs. 10/- each, at an issue price of Rs. 820/- per Equity Share (including premium of Rs. 810/- aggregating to an amount of up to Rs. 94,30,00,000/-.MoreLess
    1 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
Yes
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.

How money raised was used

Reported for the quarter to Jun 2026.

RaisedAmount raisedForSet asideSpentSpent elsewhereReason and comments
QIPDec 2025, checked by CRISIL RATINGS LIMITED350.00Investment in DHML for setting-up of new COCO stores129.6357.55NoAudit committee: The Committee has noted that there is no deviation/ variation till the quarter ended June 30, 2026.
QIPDec 2025, checked by CRISIL RATINGS LIMITED350.00Working Capital requirements135.3710.06NoAudit committee: The Committee has noted that there is no deviation/ variation till the quarter ended June 30, 2026.
QIPDec 2025, checked by CRISIL RATINGS LIMITED350.00General Corporate Purpose75.339.16NoAudit committee: The Committee has noted that there is no deviation/ variation till the quarter ended June 30, 2026.
₹ crore. Checked by is the agency appointed to monitor how the money is used. The reason and the comments are the company's, its audit committee's and its auditors' own words.